Jul 2026
Immunosuppressive effects of voclosporin in inflammatory bowel disease through targeted inhibition of SLP-76 and metabolic reprogramming.
It is suggested that VCS exerts broader immunosuppressive effects than CsA, supporting its repurposing as a therapeutic strategy and highlighting SLP-76 as a potential immunoregulatory target in IBD.
L. Loges, Michael Gabel, Annkathrin Knauss et al.
· Journal of Immunology · 0 citations